Susceptibility of trout kidney macrophages to viral hemorrhagic septicemia virus.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 1472278)

Published in Viral Immunol on January 01, 1992

Authors

A Estepa1, D Frías, J M Coll

Author Affiliations

1: INIA-Sanidad Animal, Valdeolmos, Madrid, Spain.

Articles by these authors

Regulation of the expression or recruitment of components of the DNA synthesome by poly(ADP-ribose) polymerase. Biochemistry (1998) 1.10

A comparative review on European-farmed finfish RNA viruses and their vaccines. Vaccine (2011) 1.02

Pepscan mapping and fusion-related properties of the major phosphatidylserine-binding domain of the glycoprotein of viral hemorrhagic septicemia virus, a salmonid rhabdovirus. Virology (1996) 0.90

Phospholipid interactions of a peptide from the fusion-related domain of the glycoprotein of VHSV, a fish rhabdovirus. Virology (1998) 0.88

Expression and antiviral activity of a beta-defensin-like peptide identified in the rainbow trout (Oncorhynchus mykiss) EST sequences. Mol Immunol (2007) 0.88

Salmonid viral haemorrhagic septicaemia virus: fusion-related enhancement of virus infectivity by peptides derived from viral glycoprotein G or a combinatorial library. J Gen Virol (2002) 0.87

A protein G fragment from the salmonid viral hemorrhagic septicemia rhabdovirus induces cell-to-cell fusion and membrane phosphatidylserine translocation at low pH. J Biol Chem (2001) 0.87

New tools to study RNA interference to fish viruses: Fish cell lines permanently expressing siRNAs targeting the viral polymerase of viral hemorrhagic septicemia virus. Antiviral Res (2009) 0.86

Fast neutralization/immunoperoxidase assay for viral haemorrhagic septicaemia with anti-nucleoprotein monoclonal antibody. J Virol Methods (1996) 0.85

The immunogenicity of viral haemorragic septicaemia rhabdovirus (VHSV) DNA vaccines can depend on plasmid regulatory sequences. Vaccine (2009) 0.85

Stable expression of bioactive recombinant pleurocidin in a fish cell line. Appl Microbiol Biotechnol (2006) 0.85

In vitro and in vivo differential expression of rainbow trout (Oncorhynchus mykiss) Mx isoforms in response to viral haemorrhagic septicaemia virus (VHSV) G gene, poly I:C and VHSV. Fish Shellfish Immunol (2006) 0.84

In vitro inhibition of the replication of haemorrhagic septicaemia virus (VHSV) and African swine fever virus (ASFV) by extracts from marine microalgae. Antiviral Res (1999) 0.84

Dual antiviral activity of human alpha-defensin-1 against viral haemorrhagic septicaemia rhabdovirus (VHSV): inactivation of virus particles and induction of a type I interferon-related response. Antiviral Res (2007) 0.83

Mapping of linear antibody epitopes of the glycoprotein of VHSV, a salmonid rhabdovirus. Dis Aquat Organ (1998) 0.83

Reversible inhibition of spreading of in vitro infection and imbalance of viral protein accumulation at low pH in viral hemorrhagic septicemia rhabdovirus, a salmonid rhabdovirus. J Virol (2004) 0.83

Protection and antibody response induced by intramuscular DNA vaccine encoding for viral haemorrhagic septicaemia virus (VHSV) G glycoprotein in turbot (Scophthalmus maximus). Fish Shellfish Immunol (2012) 0.82

Detection of trout haemorrhagic septicaemia rhabdovirus by capture with monoclonal antibodies and amplification with PCR. Vet Res (1995) 0.82

Rainbow trout surviving infections of viral haemorrhagic septicemia virus (VHSV) show lasting antibodies to recombinant G protein fragments. Fish Shellfish Immunol (2011) 0.82

Antibody response to a fragment of the protein G of VHS rhabdovirus in immunised trout. Vet Immunol Immunopathol (2002) 0.82

Antimicrobial peptides as model molecules for the development of novel antiviral agents in aquaculture. Mini Rev Med Chem (2009) 0.81

DNA vaccination by immersion and ultrasound to trout viral haemorrhagic septicaemia virus. Vaccine (2001) 0.81

Phosphatidylserine binding to solid-phase rhabdoviral peptides: a new method to study phospholipid/viral protein interactions. J Virol Methods (1996) 0.81

Pepscan mapping of viral hemorrhagic septicemia virus glycoprotein G major lineal determinants implicated in triggering host cell antiviral responses mediated by type I interferon. J Virol (2010) 0.81

Fish transposons and their potential use in aquaculture. J Biotechnol (2006) 0.80

Conformation- and fusion-defective mutations in the hypothetical phospholipid-binding and fusion peptides of viral hemorrhagic septicemia salmonid rhabdovirus protein G. J Virol (2004) 0.80

Improvement of DNA transfection with cationic liposomes. J Physiol Biochem (2002) 0.80

Application of inducible and targeted gene strategies to produce transgenic fish: a review. Mar Biotechnol (NY) (2005) 0.80

Improvement of transfection efficiency of epithelioma papulosum cyprini carp cells by modification of cell cycle and use of an optimal promoter. Mar Biotechnol (NY) (2004) 0.80

In vivo modulation of the rainbow trout (Oncorhynchus mykiss) immune response by the human alpha defensin 1, HNP1. Fish Shellfish Immunol (2007) 0.79

The rainbow trout TLR9 gene and its role in the immune responses elicited by a plasmid encoding the glycoprotein G of the viral haemorrhagic septicaemia rhabdovirus (VHSV). Mol Immunol (2009) 0.79

Viral-antigen dependence and T-cell receptor expression in leucocytes from rhabdovirus immunized trout. Vet Immunol Immunopathol (1999) 0.79

Recombinant protein fragments from haemorrhagic septicaemia rhabdovirus stimulate trout leukocyte anamnestic responses in vitro. J Gen Virol (1994) 0.78

Detection of hemorrhagic septicemia virus of salmonid fishes by use of an enzyme-linked immunosorbent assay containing high sodium chloride concentration and two noncompetitive monoclonal antibodies against early viral nucleoproteins. Am J Vet Res (1992) 0.78

Transfection improvements of fish cell lines by using deacylated polyethylenimine of selected molecular weights. Fish Shellfish Immunol (2009) 0.78

Improving the safety of viral DNA vaccines: development of vectors containing both 5' and 3' homologous regulatory sequences from non-viral origin. Appl Microbiol Biotechnol (2012) 0.78

Metabolically labeled cell membrane proteins in spontaneously and in SV40 virus transformed mouse fibroblasts. Biochemistry (1977) 0.78

Neutralizing-enhancing monoclonal antibody recognizes the denatured glycoprotein of viral haemorrhagic septicaemia virus. Arch Virol (1992) 0.77

Purification of the glycoprotein G from viral haemorrhagic septicaemia virus, a fish rhabdovirus, by lectin affinity chromatography. J Virol Methods (1998) 0.77

Structure, binding and neutralization of VHSV with synthetic peptides. Virus Res (1999) 0.77

Characterization of a soluble hemagglutinin induced in African swine fever virus-infected cells. Virology (1993) 0.77

In vitro analysis of the factors contributing to the antiviral state induced by a plasmid encoding the viral haemorrhagic septicaemia virus glycoprotein G in transfected trout cells. Vaccine (2010) 0.77

In vitro search for alternative promoters to the human immediate early cytomegalovirus (IE-cMV) to express the G gene of viral haemorrhagic septicemia virus (VHSV) in fish epithelial cells. Vaccine (2008) 0.77

Mapping of the G and N regions of viral haemorrhagic septicaemia virus (VHSV) inducing lymphoproliferation by pepscan. Vet Res (1995) 0.76

Different peptides from hemorrhagic septicemia rhabdoviral proteins stimulate leucocyte proliferation with individual fish variation. Virology (1995) 0.76

Characterisation of the syncytia formed by VHS salmonid rhabdovirus G gene transfected cells. Vet Immunol Immunopathol (2004) 0.76

Mitogen-induced proliferation of trout kidney leucocytes by one-step culture in fibrin clots. Vet Immunol Immunopathol (1992) 0.76

Enhancement of fish mortality by rhabdovirus infection after immunization with a viral nucleoprotein peptide. Viral Immunol (1993) 0.75

The free nucleocapsids of the viral haemorrhagic septicaemia virus contain two antigenically related nucleoproteins. Arch Virol (1991) 0.75

An in vitro method to obtain T-lymphocyte-like cells from the trout. J Immunol Methods (1997) 0.75

In vitro studies and in vivo immunisation with the first viral haemorrhagic septicaemia viruses isolated in Spain compared to international reference serotypes. Res Vet Sci (1992) 0.75

Stimulation of adherent cells by addition of purified proteins of viral hemorrhagic septicemia virus to trout kidney cell cultures. Viral Immunol (1991) 0.75

Preliminary clinical studies of C-reactive protein quantified by enzyme-linked immunoassay. Clin Chem (1987) 0.75

Cloning of myelomas and hybridomas in fibrin clots. J Immunol Methods (1988) 0.75

Microtiter-latex test for C-reactive protein, for screening large numbers of samples. Clin Chem (1987) 0.75

Selection and performance of monoclonal anti-C-reactive protein in ELISA quantitative assay. Clin Chim Acta (1988) 0.75

Replacement of the human cytomegalovirus promoter with fish enhancer and core elements to control the expression of the G gene of viral haemorrhagic septicemia virus (VHSV). J Biotechnol (2012) 0.75

Ex vivo transfection of trout pronephros leukocytes, a model for cell culture screening of fish DNA vaccine candidates. Vaccine (2012) 0.75

Identification of selective inhibitors of VHSV from biased combinatorial libraries of N,N'-disubstituted 2,5-piperazinediones. Antiviral Res (2006) 0.75

The in vitro infection of the hematopoietic stroma of trout kidney by hemorrhagic septicemia rhabdovirus. Viral Immunol (1993) 0.75

An ELISA for detection of trout antibodies to viral haemorrhagic septicemia virus using recombinant fragments of their viral G protein. J Virol Methods (2011) 0.75

Fibrous MnO2 nanoparticles with (2 x 2) tunnel structures. Catalytic activity in the total oxidation of volatile organic compounds. J Nanosci Nanotechnol (2009) 0.75